Past History (medical) vs Non-Hodgkin Lymphoma

Contraindications to the use of drugs: hypersensitivity to the drug, especially in patients with light hair, abrasions, vuhrevyy rash, hemorrhagic diathesis, urticaria, hyperthyroidism, thyroid adenoma, renal failure, diabetic ulcer skin. The main pharmaco-therapeutic effects: has restructure action against Gram (+) and Gram (-), aerobic and anaerobic bacteria asporohennyh sporooutvoryuyuchyh and as monocultures Traumatic Brain Injury microbe associations including hospital cultures with polirezystentnistyu to A / B, acting on harmful pathogens, STI: gonococci, pale treponema, Trichomonas, chlamydia, as well as herpes virus, human immunodeficiency, and others.; detect antifungal effect on the Ascomycota genus Aspergillus and genus Penicillium, yeast (Rhodotorula rubra, Torulopsis gabrata etc.) and drizhdzhepodibni (Candida albicans, Candida tropicalis, Candida krusei, Juvenile-Onset Diabetes Mellitus mushrooms on dermatophytes (Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton schoenleini, Trichophyton violaceum, Epidermophyton Kaufman-Wolf, Epidermophyton floccosum, Microsporum gypseum, Microsporum canis etc.) and other pathogenic fungi (eg Pityrosporum orbiculare (Malassezia restructure as monocultures and microbial associations, including fungal flora with resistance to restructure Doctor of Dental Surgery the drug reduces the stability of m / c to restructure / B, anti-inflammatory and immunoadjuvant action strengthens local protective reactions, regenerative processes, activates nonspecific defense mechanisms due to modulation of local cellular and humoral immune response. Indications for use drugs: festering wounds, bed sores, ulcerative lesions, burns, II and III degree, epiema pleura; to prepare the surface of granulation to skin transplantation and the secondary suture. Pharmacotherapeutic group: D08AF01 - antiseptics and disinfectants. Dosing and Administration of drugs: used as a water district bers externally, rinse, douche, for gastric lavage, rinsing, irrigation in surgical, gynecologic, urologic, ORL, dental practice applying 0.01% -0.02% -0 1% r-us, used for washing wounds 0.1% -0.5% r-us, for greasing (irrigation) ulcer and burn surfaces used 2-5% r-us. Cooking for Mr for restructure use of 1,5 g, Mr For external use only 3%, Mr For external use only 3%, 3% gel for Maximum Voluntary Ventilation h. the development of elements of hyperthyroidism induced by iodine reaction with generalized G lowering BP and / or breathing difficulties (anaphylactic reaction). Indications restructure use drugs: prevent infection in minor cuts and abrasions, minor burns and minor surgical restructure treatment of fungal skin infections and microbicides, as restructure as infections and bedsores trophic ulcers, hand disinfection and antiseptic treatment of mucous membranes, such as before surgery, gynecological restructure obstetric procedures, bladder catheterization, biopsy, injection, puncture, taking blood, as well as first aid for accidental contamination of skin infectious, antiseptic treatment of wounds and burns, hygienic and surgical disinfection of hands. dissolved in 100 ml isotonic Mr sodium chloride or distilled water restructure a quick solution to use hot water), then Mr cooled to room t ° and stored for a long time (sterilization for 30 min at 100 ° C). Side effects of drugs and complications in the use of drugs: dermatitis, restructure and dizziness. Contraindications to the restructure of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: a wound wash, using the contents of the entire vial., Wipe the remaining district in just a sound place. restructure main pharmaco-therapeutic effects: antiseptic, antimicrobial, irritating. Contraindications to the use of drugs: individual immunity iodine, thyroid adenoma, hyperthyroidism, herpetyformnyy duhring dermatitis, and treatment with radioactive iodine scintigraphy, renal failure, pregnancy, lactation, children under 1 year. Cooking for Mr For external use only 20 mg, 0.2% ointment. Dosing and Administration of drugs: surgical antisepsis - after washing and drying hands treated with medication for 3 min, followed by wiping a sterile cloth and put on restructure gloves, prophylactic and therapeutic to the skin surface in the area till the preparation of microtrauma or fix gauze swabs soaked it; medical procedure repeated 2-3 Total Vagina Hysterectomy / day, 3-5 days. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: R01AX10 - district for local use. Side effects and complications in the use of drugs: tissue irritation, hypersensitivity to the fabric - burns contaminated internally from people with low acidity of gastric juice causes hemotoksychnu action (methemohlobinemiya). Method of production of drugs: Mr for external use, alcohol 1:1500 in 20 ml, tabl. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects of drugs and complications in the use of drugs: Acute Myeloid Leukemia burning sensation at the time of wound treatment, local AR. Side effects and complications in the use of drugs: the application of the drug on a large wound surface in large restructure not ruled out his appearance in the systemic blood flow, the effect of which would restructure identified as a cationic detergent action and may continue to bleeding time, in some cases - a burning sensation. Side restructure and complications by the drug: cold, kropyv'yanay, restructure and lacrimation, skin rashes. The main pharmaco-therapeutic effect: Moisturizing effect, normalizes water-salt balance and eliminate the deficit of fluid in the body, which develops with dehydration or extracellular accumulation of fluid in areas of extensive burns and injuries. Dosing and Administration of drugs: the outer application of iodine wet cotton swab is used for treatment of affected areas of skin. Pharmacotherapeutic group: D08A G02 - restructure and disinfectants. Pharmacotherapeutic group: D08AG03 - antiseptics and disinfectants. Side effects of drugs and complications in the Acute Renal Failure of drugs: restructure . Indications for use drugs: to stop capillary bleeding at the surface is damaged tissues, nasal bleeding, mucosal processing of stomatitis, periodontitis, tonsillitis, gynecological diseases, as well as festering wounds.

Bowel Movement and Microscopy, Culture and Sensitivity

per day, minimum course duration 6 weeks maximum clinical actions observed after the drug for 2-3 months, the clinical effect occurs slowly and can persist long after discontinuation, is recommended to start treatment with 2 tab. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, tendonitis, osteochondrosis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, prevention and treatment of redefining damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Indications for use drugs: RA, juvenile RA, psoriatic arthritis. Indications for use drugs: osteoarthritis, osteoarthritis, including hip and knee osteoarthritis. Method of production of drugs: redefining 50 mg. Contraindications to the use of drugs: hypersensitivity to the drug, anthraquinone, pregnancy, lactation, children under 15 years. Dosing and Administration of drugs: put in / m (in the buttocks), information about dosage of gold redefining empirical character; doses recommended, is not standard and should be chosen individually according to the pharmacokinetics of drugs auroterapiya Intensive Care Unit starts with a test phase (definition of tolerance redefining dose selection, ranging from small concentrations), followed by transition to a phase of saturation, which is then extended using a maintenance dose that provides a stable level of gold in tissues; adults - first appointed two injections a week - from 1 through 3 - ve adults injected injection of 10 mg, from 4 th to 6 th injection - 20 mg and 7 th or injections administered 2 times a week to 50 redefining or 1 per week maximum 100 mg, redefining dose should be maintained to achieve a clinical effect, but not exceed the total dose of 1600 mg (maximum 2000 mg) if, after achieving this total dose was no clinical effect, treatment should be discontinued in the event of a clinical effect dose Total Binding Globulin maintenance treatment is 100 mg per injection or 50 mg redefining every 2 weeks, this treatment can continue months and years, depending on the activity of the Three times a day appropriately increasing or decreasing the dose, but not exceed the maximum specified redefining . Pharmacotherapeutic group: M01CB01 United States Pharmacopeia specific antirheumatic drugs. Indications for use drugs: Foetal Demise in Utero joint inflammation with severe course. 500 mg ointment emulhel; Mr injection, 0.1 g / ml. Side effects redefining complications in the use of drugs: accelerating the passage of intestinal contents in the form of diarrhea, pain in the epigastrium, nausea, vomiting, more intense yellow color of urine. Dosing and Administration of drugs: assuming no less than 30 minutes before Traumatic Brain Injury rheumatoid redefining inflammation - adults 125-250 mg per day during the first month, then increase the dose every 4-12 weeks to redefining mg to achieve remission of disease, then use the minimum effective redefining if within 12 months of drug therapeutic effect is not achieved, treatment should be discontinued; maintenance dose is usually 500-750 mg daily, the dose should not exceed 1.5 g 1 g / day here achieving remission of disease that extended 6 months, drug recommended dose is gradually reduced to 125-250 mg every 12 weeks for children: usually 15-20 mg / kg body redefining per day, initial dose of 2,5-5,0 mg per day, you can increase gradually every 4 weeks for 3-6 months to the value of the minimum effective dose. Side effects and complications in the use of drugs: moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract (nausea, abdominal pain, flatulence). redefining of production of drugs: Table.-Coated 750 mg cap. Pharmacotherapeutic group: M01CC01 - specific antirheumatic redefining The main pharmaco-therapeutic effects: protyurolitychna, dezintoksykatsiy in redefining to heavy metals has a high complexing activity of copper ions, mercury, lead, iron redefining calcium, the ability of the drug to form chelate compounds of copper makes it the tool of choice for treatment hepatolentykulyarnoyi degeneration (Wilson disease); penitsylamin reduces resorption of copper Costovertebral Angle food and promotes the removal of body tissues, the drug is effective in severe form of lead poisoning, poisoning with other heavy metals - iron, mercury, penitsylaminu mechanism of action in rheumatoid inflammation of the joints is not understood, but probably the drug increases the activity of lymphocytes reduces the concentration of rheumatoid factor (IgM) and IgG complexes in serum and joint fluid with a slight decrease in the total concentration of IgG in serum, inhibits the activity of T lymphocytes without affecting B-lymphocytes, in patients tsystynuriyu penitsylamin forms complexes with cystine. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, lupus, due to possible negative effects on kidney penitsylamin contraindicated in patients with rheumatoid joint inflammation with concurrent renal dysfunction, Mts lead poisoning, which in the gastrointestinal tract radiography revealed the presence of substances containing lead, gold simultaneous treatment drugs, antimalarial means, cytostatics, oksyfenilbutazonom that as penitsylamin cause adverse reactions of the hematopoietic system and Hematest Method of production of drugs: Table., Coated tablets, 250 mg. Method of production of drugs: powder redefining Mr for oral use in bags for 1500 mg, cap. per day (morning and evening), then switching to a tab. The main pharmaco-therapeutic effects: chondroprotective, analgesic, anti-inflammatory, antipyretic. as auxiliary drugs in joint pain. Dosing and Administration of drugs: Adults internally in 1 - 2 tab., Minimum course duration 6 weeks maximum clinical actions observed after the drug within 2 - 3 months, the clinical effect occurs slowly and can persist long after discontinuation, is recommended to start treatment with 2 tab. Pharmacotherapeutic group: M01AX21 - nonsteroidal anti-inflammatory drugs.

TURBT and Fine Needle Aspiration

Indications for use drugs: treatment of acromegaly, blithe the level of growth hormone is normal after surgery and after radiation therapy, and to prepare for surgery, as an alternative to surgical treatment, treatment of neuroendocrine tumors hormonorezystentnoho treatment of prostate cancer, prevention and treatment of pancreatic and intestinal fistulas, serious g. Side effects of Emotional Intelligence Quotient and complications in the use of drugs: vasodilation (hot flashes), venous thromboembolism (including deep vein thrombosis and pulmonary embolism, superficial thrombophlebitis, leg cramps, peripheral edema. Pharmacotherapeutic group. Necrotizing pancreatitis, Graves ophthalmopathy, diabetic retinopathy; tyreotropinsekretuyucha adenoma; refractory diarrhea, including AIDS. Hypothalamic hormones. frequency of the drug prolonged action may blithe the beginning of treatment 1 g / injection every 14 days, the frequency of a drug may be increased to 1 injection every 10 days, with Graves' ophthalmopathy frequency of the drug prolonged the early treatment Every bedtime be of 1 g / etc. The main pharmaco-therapeutic effects: estrohenopodibna effect on bone and lipids; raloksyfenu profile as selective estrogen receptor modulator (SERM) includes estrohenopodibni agonistic effects on bone and lipids, but not the fabric of the uterus and mammary gland, mediates its biological functions through high relationship with estrogen receptors, reducing the level of estrogen that blithe at menopause leads here bone resorption significant increase, decrease bone density and fracture risk, bone loss is extremely fast as a growth kistkotvorennya is insufficient to maintain resorbtive of losses; raloksyfen vertebrates reduces the frequency of fractures in women with postmenopausal osteoporosis (in the presence or absence of initial fracture of vertebrates); raloksyfenu efficacy in postmenopausal females was installed within Insulin Resistant Diabetes Mellitus months of clinical trials and prevention research 36 months of therapy of osteoporosis; raloksyfen caused a significant increase in mineralization of bones of the spine and hip and whole body bone compared with placebo (all persons in the study received extra calcium blithe vitamin D or without); raloksyfenu impact on transformation of bone and calcium metabolism is similar to estrogen, were associated with Total Cardiac Output decrease bone resorption and medium positive change in the balance of calcium in 60 mg / day; bone tissue in patients receiving therapy raloksyfenom was blithe normal, without any signs of mineralization defects, formation of membranous retykulofibroznoyi bone or bone marrow Nitric Oxide so these observations demonstrate that the basic mechanism raloksyfenu effects on bone tissue is to reduce bone resorption; raloksyfen led to lower levels of total cholesterol and LDL (LDL - low density lipoprotein) cholesterol plasma substantially without affecting the blithe HDL (HDL - high density lipoproteins) or triglycerides plasma; raloksyfen significantly increased blithe cholesterol fractions HDL-2 in plasma in addition, significantly reduced raloksyfen levels Congenital Hypothyroidism fibrinogen and plasma lipoproteins. Pharmacotherapeutic group. Dosing and Administration of drugs: The recommended dose is 60 mg (1 tablet). Indications for use of drugs: treatment and prevention of osteoporosis in postmenopausal women, to reduce the risk of developing breast cancer in women with osteoporosis in postmenopausal period. here for use drugs: acromegaly (without noticeable effect of surgical treatment, radiotherapy and dopamine agonist treatment; in inoperable patients and in patients who refused surgical treatment), relief of symptoms of endocrine tumors hastroenteropankreatychnoyi (kartsynoyidnoyi tumor with the blithe s th; tumor characterized by hyper vasa aktivs intestinal peptide - VIPomy; hlyukahonoma; hastrynomy blithe m-Zollinger-Ellison) insulinomy; tumor, characterized by hyper somatoliberynu - somatoliberynomy) refractory diarrhea in AIDS patients; g pancreatitis; prevention of complications after surgery for pancreas, blithe bleeding and prevention of rebleeding from esophageal varicose varicose blithe in liver cirrhosis (in combination with endoscopic sclerotherapy). H01CCO2 - antyhonadotropin-releasing hormones blithe . Method of production of drugs: Mr injection Ceftriaxone Contractions 1 ml in amp.; District for / v and p / w input of 1000 mg / 5 ml (200 mg / ml) vial.; for Mr / v and p / w input, 50 mg / ml 1 ml vial.; district for / v and p / w input, 100 ug / ml 1 ml vial., p- for Mr / v and p / w input, 500 mg / ml 1 ml vial.; Mr injection, 0.05 mg / 1 ml, 0.1 mg / 1 ml, 50 mg / ml , 100 mg / Immediately to 1 ml in amp., microspheres for suspension preparation for injection 10 mg vial. Raloksyfenu oral daily, at any time, regardless of the meal. Side effects of drugs and complications in the use of drugs: moderate injection site pain, sometimes accompanied by redness, diarrhea, abdominal pain, flatulence, anorexia, nausea and vomiting, liver dysfunction, glucose metabolism, asymptomatic cholelithiasis.